{"database":"NODE","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"submitter":["Chunmei Kuang"],"technology_type":["ATAC-seq"],"full_dataset_link":["https://www.biosino.org/node/experiment/detail/OEX00016790"],"experiment_platform":["Illumina HiSeq 2500"],"experiment_library_layout":["Paired"],"experiment_library_selection":["PCR"],"sample_count":["2"],"tissue":["['cord Blood']"],"taxonomy":["['Homo sapiens']"],"experiment_protocol":["50000 MKs treated with vehicle or serine at day 12  were collected for ATAC-seq (Novogene, China)."],"repository":["NODE"],"additional_accession":[]},"is_claimable":false,"name":"OEX_Chunmei_2204302123","description":"we identify serine serves as a key metabolic factor that suppresses megakaryopoiesis and thrombopoiesis and eventually causes the thrombocytopenia in multiple myeloma. To identify the potential methylated substrates regulated by serine, we performed assay for transposase-accessible chromatin using sequencing (ATAC-seq) in MKs treated with vehicle or serine at day 12.","dates":{"publication":"2022-12-19","submission":"2022-04-30"},"accession":"OEX00016790","cross_references":{"NODE":["OEP00003357"]}}